Marksans Pharma Ltd.
MARKSANS Share PricePharmaceuticals & Drugs
₹172
2.5 (1.5%)
As on September 9, 2025
Exchange Scrips: BSE524404NSEMARKSANSISININE750C01026
Market Cap ₹ 7,785 Cr
P/E Ratio 20.48
Dividend Yield 0.47 %
Performance
Market performance
Open170.85
High174.2
Volumes9,30,414
Prev172
Low169
As on2025-09-09
Historical performance
1 Year High358.7
3 Year High358.7
5 Year High358.7
1 Year Low165.52
3 Year Low45.4
5 Year Low38.6
Fundamentals
Company Valuation
Market Cap (₹Cr)
7,785
Face Value (₹)
1
P/E Ratio
20.48
Dividend Yield
0.47 %
Investment Returns
1 Year
-33.4%
3 Years
225.4%
5 Years
275.1%
10 Years
103.6%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 171 | Bullish |
| 10-DMA | 170.47 | Bullish |
| 20-DMA | 177.66 | Bearish |
| 50-DMA | 217.05 | Bearish |
| 100-DMA | 228.85 | Bearish |
| 200-DMA | 244.03 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 2 | 2 | 2 | 2 | 2 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 2 | 2 | 2 | 2 | 2 |
| Public Investors | 256219 | 257271 | 259811 | 248843 | 235498 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 20.48.
- 3Y Stock Price CAGR of the stock is 48.0.
- The stock has a beta of 1.4.
- In the last financial year, the company had an EBITDA of ₹5990 Million.
- The company generated revenue of ₹26228 Million in the previous financial year.
Marksans Pharma Ltd.
1722.5 (1.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 652528.5
No. of Shares: 3794 (Approx)
Performance:-34.7%
P/L: ₹-347471.5
Top Gainers
| Symbol | Change% |
|---|---|
| ITDC | 653.6(20%) |
| LASA | 12.74(20%) |
| PRECAM | 254.93(16%) |
| JTEKTINDIA | 181.94(15%) |
| QUICKHEAL | 335.1(14%) |
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent